Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analysesEun Young Kang, P. Mackenzie, Cécile Le Page et al.|Modern Pathology|2020Cited by 43